SLET 90% cheaper than CLET

A simplified version of a treatment pioneered in India to treat limbal stem cell deficiency (LSCD) has demonstrated comparable efficacy to its predecessor but at just 10% of the cost, according to a paper published in the British Journal of Ophthalmology.

 

Central serous chorioretinopathy cases

Central serous chorioretinopathy (CSCR) is the fourth most common retinal disease¹. But unlike other common retinal diseases, CSCR commonly affects working-age...

Sun, slopes and the right eyewear

As cold weather begins to blanket the Southern Hemisphere, your patients are likely to be thinking about their winter sports activities. While some might...

Dr Dianne Sharp: regarding the retina

Well-known champion of retina disease patients Dr Dianne Sharp is retiring. So we asked our optometrist writer Louise Wood to find out how it all came...

Business planning – a must have for every retail practice!

All practices should have a business plan, which for small or medium-sized practices could be as simple as a one-page document. A larger and more complex...

CASE STUDY: The fun comes undone

A healthy 40-year-old male presented with a one-week history of blurred central vision in his right eye. He had no medical history of note. His left eye...

Bottom Banner Advert